Skip to content

Trial Summary

CS1001-101

Acronym:

CS1001-101

ACTRN/NCT /ethics:

NCT03312842

Scientific title:

A Phase Ia/Ib Study of CS1001 in Subjects With Advanced Solid Tumors

Sponsor / Cooperative group:

Cstone Pharmaceuticals

Trial & Patient Characteristics

Cancer TypeAll cancers
Trial TypeTreatment
PhasePhase I
Age Range18 years to 75 years
SexBoth
Tumour Stream -
Cancer StageLocally Recurrent or Locally Advanced, Metastatic or Widespread
Anticipated Start Date2017-10-19
Anticipated End Date2021-03-01

Participating Hospitals

HospitalAshford Cancer Centre Research
Clinical Trial CoordinatorSue Yeend
Emailsyeend@adelaidecancercentre.com.au
Phone08 8292 2240
Principal InvestigatorDr Anna Mislang
Recruitment StatusRecruiting